👉University of Michigan Scleroderma Program leading the way through excellence in clinical care, teaching, & research #scleroderma tweets≠advice Follow≠endorse
Ann Arbor, MI
Joined July 2017
- Tweets1.5K
- Following87
- Followers3.4K
- Likes1.8K
Pinned Tweet
We've received very touching #sclerodermastories from patients & family. Read them all at the link below. Please consider supporting the Michigan Medicine Scleroderma Program on #GivingBlueday 11/27/18, at medicine.umich.edu/dept/intm… … #medicineneedsvictors #victorsinthehouse #Rheum
Exciting data on CAR-T from @Worldsclerofnd meeting in Athens in #scleroderma. Complete B cell depletion in tissue, response in RNA pol 3 Ab, and ++large clinical response. Clinical trials starting comparing CAR-T to standard of care therapies with Novartis and BMS.
Join me and Dr Monalisa Ghosh to get an update on cell therapy in # scleroderma on Friday, December 12 - 2:00 p.m. ET. Sponosred by @scleroderma us02web.zoom.us/webinar/regi…
SLS 3 is published. acrjournals.onlinelibrary.wi…
1. Upfront MMF+PFD vs. MMF+PLA
2. Underpowered due to Covid
3. No difference in primary end- FVC%
4. ⬆️AE and discont with MMF+PFD
What else did we learn?
A. Trends favor MMF+PFD in PROs and in HRCT QILD
B. Need well powered trials
Dr. Dinesh Khanna retweeted
✨How can we better understand and treat fibrotic diseases?
Meet Dr. Dinesh Khanna at #ECM2026. @sclerodermaUM
He is a Professor of Medicine and Director of the University of Michigan (@UMich) Scleroderma Program , pioneering precision research in #scleroderma and #fibrosis.
Dr. Dinesh Khanna retweeted
📢 There were “clinical improvements in lung function and skin thickness in patients with severe refractory #SSc, with 96% remaining off SSc-directed therapies during the follow up,” said Dr. Dinesh Khanna @sclerodermaUM.
healio.com/news/rheumatology…
A lot of enthusiasm about CAR-T therapy in #scleroderma. Data from Phase 1 trial sclerodermanews.com/news/car…
Proud moment. Neha Khanna, 2nd year undergraduate at UM presenting first author poster at #ACR25. Thanks to her mentor @elizatsou and @UMIntMed
Dr. Dinesh Khanna retweeted
📢 “Preliminary meaningful improvement in #lung function and #skin thickness was observed” in patients with #SSc who received #CARTcelltherapy, said Dr. Dinesh Khanna @sclerodermaUM.
Read the full story from #ACR25 here 👇
healio.com/news/rheumatology…
#ACR2025. Exciting data on CAR-T in SSc.
Oct 26: Efficacy and Safety of BMS-986353, a CD19-Directed Chimeric Antigen Receptor T Cell Therapy: Phase 1 Trial in SSc
Oct 27: RESET-SSc: Clinical Trial Evaluating Rese-cel Autologous 4-1BB CD19-CAR T Cell Therapy in Phase 1 in SSc
Dr. Dinesh Khanna retweeted
🫁Better understand key characteristics and diverse subtypes of fibrosing #interstitiallungdisease with our NEW CE #Webinar Series! Register Now: ow.ly/WJSc50X5a8q
@sclerodermaUM
@DrBernstein
#Rheumatology #rheumatologists #InterstitialLungDisease #LungDisease #CME
Dr. Dinesh Khanna retweeted
Interested in a career in scleroderma and related disorders? Join one of the largest programs with robust clinical research and trials. We are actively recruiting! @UMIntMed
nejmcareercenter.org/job/920…
📷
Join me and @Kahlenberglab today at 11 am ET ecm-congress.org/ecm-pharmac… Thanks to @Nordic_Bio for inviting us!
Interested in a career in scleroderma and related disorders? Join one of the largest programs with robust clinical research and trials. We are actively recruiting! @UMIntMed
nejmcareercenter.org/job/920…
📷
Interested in a position at U-M scleroderma program? Expertise in analyzing omics data. We are leading center in clinical trials and one of the largest scleroderma program.
careers.umich.edu/job_detail…
Dr. Dinesh Khanna retweeted
Join us today at 12 pm for Grand Rounds on "Systemic Sclerosis: An Update" presented by @sclerodermaUM, professor in the Division of Rheumatology.
Learn more: medschool.umich.edu/departme…
ALT internal medicine grand rounds on systemic sclerosis presented by Dr. Dinesh Khanna August 15th
Delighted to present @UMIntMed grand rounds today at noon ET. Systemic Sclerosis- an update! Join at umich.zoom.us/j/97732438261
Password: 606879
Dr. Dinesh Khanna retweeted
DID YOU KNOW? >30% of Systemic Sclerosis pts present without Raynauds!. Data from 2 large US cohorts, of SSc dx with puffy fingers/hands or other symptoms. Such patients presented with more severe skin and musculoskeletal disease. buff.ly/t6mFdB9
Our first person Susan Chrysogelos who received CAR-T #scleroderma @UMIntMed @srfcure @scleroderma michiganmedicine.org/health-… #findcureforscleroderma
Dr. Dinesh Khanna retweeted
Bringing rheumatology closer to haematology. CAR-T therapy is showing tremendous promise in autoimmune conditions esp difficult to treat cases. #eular2025
Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
